-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen Inc. and Stoke Therapeutics Announce Promising Clinical Data for Zorevunersen in Treating Dravet Syndrome at International Epilepsy Congress

Reuters·08/25/2025 11:00:16

Please log in to view news